Ophthalmologist Randy Epstein, MD, performed the procedure. Dr. Epstein is CEO of Chicago Cornea Consultants.
The newly approved IOLs are designed to improve patients’ distance, intermediate and near vision after surgery. Alcon commercially launched the IOLs in the U.S. in late August.
More articles on supply chain:
‘Don’t re-invent the wheel’: A message for ASC supply chain leaders
Ospitek releases new ASC software
3 ways to ensure smooth adoption of new ASC technology
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
